News Center

The retreat provided an opportunity for Massey’s clinical research partners from across the state to learn about promising clinical trials and discuss administrative topics related to clinical research operations and collaborations. This year’s discussions focused on Massey’s UPBEAT clinical trial for breast cancer patients, open and pending clinical trials for neuro-oncology and updates on cancer care delivery research.

Massey’s Clinical Research Affiliation Network brings clinical trial offerings to seven affiliated community hospital and oncology practices in order to expand access to clinical trials, increase participant enrollment and ultimately improve cancer care in Virginia and beyond. The Minority/Underserved NCI Community Oncology Research Program grant (NCORP-MU) received by Massey in 2014, provides additional support for the statewide research affiliation network, with particular emphasis on access to cancer research for minority and underserved patients in the Commonwealth. Massey is one of 14 NCORP sites around the country that is designated as a Minority/Underserved community site.

Every year, clinical research affiliates who recruited the most patients to research studies are honored. This year, Virginia Cancer Institute received an award for the most treatment accruals and Centra Lynchburg Hematology Oncology received awards for most overall accrual and data performance.

Khalid Matin, M.D., F.A.C.P., medical director of community oncology and clinical research affiliations at Massey, provided closing remarks.

“Thank you to everyone came from around the state to attend the symposium and the retreat today, as well as all our affiliates who continue to work with us to provide cutting-edge clinical trials,” said Dr. Matin. “As this conference grows each year, it’s exciting to see so many health care providers and researchers band together for the common goal of improving cancer care in Virginia.” 

Written by: Melissa Mitchell